We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
(-6.4%)
Cap. Flow
-$4.97M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kodiak Sciences
KOD
|
+$3.17M |
| 2 |
Constellium
CSTM
|
+$2.67M |
| 3 |
Kontoor Brands
KTB
|
+$2.5M |
| 4 |
Semtech
SMTC
|
+$2.34M |
| 5 |
Crane NXT
CXT
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$2.96M |
| 2 |
TUP
Tupperware Brands Corporation
TUP
|
+$2.45M |
| 3 |
PRTY
Party City Holdco Inc.
PRTY
|
+$2.4M |
| 4 |
nVent Electric
NVT
|
+$2.32M |
| 5 |
NCR Voyix
VYX
|
+$2.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.38% |
| 2 | Industrials | 16.37% |
| 3 | Technology | 14.13% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Financials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
476
DELISTED
Epizyme, Inc
EPZM
| $538K | 0.07% |
467,836
+343,336
| +276% | +$560K |
|
477
Apogee Enterprises
APOG
$908M
| $537K | 0.07% |
11,316
+110
| +1% | +$5.12K |
|
478
Arcutis Biotherapeutics
ARQT
$3.18B
| $536K | 0.07% |
+27,851
| New | +$471K |
|
479
FerroAtlántica
GSM
$839M
| $536K | 0.07% |
69,576
+3,406
| +5% | +$23.2K |
|
480
ZIM Integrated Shipping Services
ZIM
$3.24B
| $535K | 0.07% |
7,360
-23,419
| -76% | -$1.62M |
|
|
AMTI
481
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $534K | 0.07% |
71,073
+6,920
| +11% | +$57.3K |
|
482
Peoples Bancorp
PEBO
$1.47B
| $531K | 0.07% |
16,964
-23,785
| -58% | -$771K |
|
483
V2X
VVX
$2.65B
| $531K | 0.07% |
14,818
+7,100
| +92% | +$303K |
|
|
KNTE
484
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $531K | 0.07% |
+47,175
| New | +$519K |
|
485
Amkor Technology
AMKR
$13.7B
| $530K | 0.07% |
+24,418
| New | +$553K |
|
486
LyondellBasell Industries
LYB
$19.2B
| $530K | 0.07% |
+5,151
| New | +$513K |
|
|
LL
487
DELISTED
LL Flooring Holdings, Inc.
LL
| $530K | 0.07% |
+37,805
| New | +$577K |
|
488
Berkshire Hathaway Class A
BRK.A
$1.12T
| $529K | 0.07% |
1
-1
| -50% | -$485K |
|
489
Calix
CALX
$2.39B
| $528K | 0.07% |
12,294
-21,972
| -64% | -$1.11M |
|
490
Liquidity Services
LQDT
$1.32B
| $528K | 0.07% |
30,829
+16,117
| +110% | +$291K |
|
491
Insperity
NSP
$2.01B
| $528K | 0.07% |
+5,253
| New | +$524K |
|
492
Westlake Corp
WLK
$9.9B
| $528K | 0.07% |
4,275
-719
| -14% | -$78.4K |
|
493
Enphase Energy
ENPH
$5.53B
| $526K | 0.07% |
2,605
+978
| +60% | +$154K |
|
494
StoneX
SNEX
$7.94B
| $523K | 0.07% |
35,650
+7,249
| +26% | +$101K |
|
495
Arrowhead Research
ARWR
$12.4B
| $522K | 0.07% |
+11,346
| New | +$562K |
|
|
NFBK
496
DELISTED
Northfield Bancorp
NFBK
| $522K | 0.07% |
+36,320
| New | +$571K |
|
497
XP
XP
$8.39B
| $522K | 0.07% |
+17,338
| New | +$541K |
|
498
Turning Point Brands
TPB
$1.74B
| $521K | 0.07% |
+15,307
| New | +$519K |
|
499
Benchmark Electronics
BHE
$2.96B
| $520K | 0.07% |
+20,777
| New | +$530K |
|
|
GOOD
500
Gladstone Commercial Corp
GOOD
$627M
| $520K | 0.07% |
23,598
+9,970
| +73% | +$224K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2022 Portfolio in Review
As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
- GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
- GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
- GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
- GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
- GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
- GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
- GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.
Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.